Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Blanco

Showing results (241-250 of 256) with videos related to

Pageof 26
Sort By:
Plos One|May 13, 2016
Plasma Levels of Monocyte Chemoattractant Protein-1, n-Terminal Fragment of Brain Natriuretic Peptide and Calcidiol Are Independently Associated with the Complexity of Coronary Artery DiseaseRoberto Martín-Reyes, Juan Antonio Franco-Peláez, Óscar Lorenzo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 24, 2004
Failure of cetirizine to prevent nevirapine-associated rash: a double-blind placebo-controlled trial for the GESIDA 26/01 StudyHernando Knobel, José M Miró, Beatriz Mahillo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2025
Dolutegravir/Lamivudine for Maintenance of Virological Suppression in Persons with Historical Suspected or Confirmed Resistance to Lamivudine: Week 48 Results of a Single-Arm, Open-Label, Multicentre, Phase IIA Clinical TrialRosa De Miguel, María de Lagarde Sebastian, José Luis Blanco Arévalo, et al.
AIDS and Behavior|June 22, 2022
Chemsex Practices in PrEP: Beyond Addiction and Risk Toward a Healthy Sex Life-Baseline Experiences from a Hospital-Based PrEP Program in Barcelona, SpainLorena De La Mora, Ainoa Ugarte, Maria Martínez-Rebollar, et al.
HIV Medicine|October 25, 2024
Should we measure quality of life among people with HIV? A multicentre survey of physicians' opinions in SpainRebeca Izquierdo, Inés Suárez-García, Teresa Gómez-García, et al.
Microorganisms|November 25, 2023
Mpox: Clinical Outcomes and Impact of Vaccination in People with and without HIV: A Population-Wide StudyRaquel Martín-Iguacel, Carles Pericas, Andreu Bruguera, et al.
Infectious Diseases and Therapy|June 11, 2026
Effectiveness, Sex Differences, and Patient Experience in Real-World Use of Long-Acting Cabotegravir and Rilpivirine: Results from a Prospective StudyAna González-Cordón, Júlia Calvo, Leire Berrocal, et al.
Nature Communications|May 24, 2022
Proton stopping measurements at low velocity in warm dense carbonS Malko, W Cayzac, V Ospina-Bohórquez, et al.
Lancet (London, England)|February 24, 2023
Mpox in people with advanced HIV infection: a global case seriesOriol Mitjà, Andrea Alemany, Michael Marks, et al.
Lancet (London, England)|November 20, 2022
Human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks: a global case seriesJohn P Thornhill, Romain Palich, Jade Ghosn, et al.
Pageof 26

Showing results (241-250 of 256) with videos related to

Sort By:
Pageof 26
Plos One|May 13, 2016
Plasma Levels of Monocyte Chemoattractant Protein-1, n-Terminal Fragment of Brain Natriuretic Peptide and Calcidiol Are Independently Associated with the Complexity of Coronary Artery DiseaseRoberto Martín-Reyes, Juan Antonio Franco-Peláez, Óscar Lorenzo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 24, 2004
Failure of cetirizine to prevent nevirapine-associated rash: a double-blind placebo-controlled trial for the GESIDA 26/01 StudyHernando Knobel, José M Miró, Beatriz Mahillo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2025
Dolutegravir/Lamivudine for Maintenance of Virological Suppression in Persons with Historical Suspected or Confirmed Resistance to Lamivudine: Week 48 Results of a Single-Arm, Open-Label, Multicentre, Phase IIA Clinical TrialRosa De Miguel, María de Lagarde Sebastian, José Luis Blanco Arévalo, et al.
AIDS and Behavior|June 22, 2022
Chemsex Practices in PrEP: Beyond Addiction and Risk Toward a Healthy Sex Life-Baseline Experiences from a Hospital-Based PrEP Program in Barcelona, SpainLorena De La Mora, Ainoa Ugarte, Maria Martínez-Rebollar, et al.
HIV Medicine|October 25, 2024
Should we measure quality of life among people with HIV? A multicentre survey of physicians' opinions in SpainRebeca Izquierdo, Inés Suárez-García, Teresa Gómez-García, et al.
Microorganisms|November 25, 2023
Mpox: Clinical Outcomes and Impact of Vaccination in People with and without HIV: A Population-Wide StudyRaquel Martín-Iguacel, Carles Pericas, Andreu Bruguera, et al.
Infectious Diseases and Therapy|June 11, 2026
Effectiveness, Sex Differences, and Patient Experience in Real-World Use of Long-Acting Cabotegravir and Rilpivirine: Results from a Prospective StudyAna González-Cordón, Júlia Calvo, Leire Berrocal, et al.
Nature Communications|May 24, 2022
Proton stopping measurements at low velocity in warm dense carbonS Malko, W Cayzac, V Ospina-Bohórquez, et al.
Lancet (London, England)|February 24, 2023
Mpox in people with advanced HIV infection: a global case seriesOriol Mitjà, Andrea Alemany, Michael Marks, et al.
Lancet (London, England)|November 20, 2022
Human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks: a global case seriesJohn P Thornhill, Romain Palich, Jade Ghosn, et al.
Pageof 26